Xvivo Perfusion AB's total assets for Q1 2026 were kr2.47B, an increase of 4.00% from the previous quarter. SE:XVIVO total liabilities were kr299.60M for the fiscal quarter, a 14.94% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.